Skip to main content

Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis



Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we performed a systematic review and meta-analysis to assess the global prevalence of human Ascaris infection from 2010 to 2021.


We searched MEDLINE/PubMed, and Scopus databases for studies measuring prevalence of Ascaris infection, published between 1 January 2010 and 1 January 2022. We included studies of the general human population in endemic regions, which used accepted coprodiagnostic methods, and excluded studies of people with occupations with an increased risk or probability of ascariasis and/or specific diseases other than ascariasis. We applied random-effects models to obtain pooled prevalence estimates for six sustainable development goal regions of the world. We extrapolated the prevalence estimates to the global population in 2020, to estimate the number of individuals with Ascaris infection. We conducted multiple subgroup and meta-regression analyses to explore possible sources of heterogeneity, and to assess relationships between prevalence estimates and demographic, socio-economic, geo-climatic factors.


Of 11,245 studies screened, we analysed 758 prevalence estimates for a total number of 4,923,876 participants in 616 studies from 81 countries. The global prevalence estimated was 11.01% (95% confidence interval: 10.27–11.78%), with regional prevalences ranging from 28.77% (7.07–57.66%) in Melanesia (Oceania) to 1.39% (1.07–1.74%) in Eastern Asia. We estimated that ~ 732 (682–782) million people harboured Ascaris worldwide in 2021. The infected people in Latin America and the Caribbean region had a higher prevalence of high intensity infection (8.4%, 3.9–14.1%). Prevalence estimates were higher in children, and people in rural communities or in countries or regions with lower income and human development indices. There was a trend for a higher prevalence in regions with increasing mean annual relative humidity, precipitation and environmental temperature.


Our findings indicate that, despite a renewed commitment by some communities or authorities to control ascariasis, a substantial portion of the world’s human population (> 0.7 billion) is infected with Ascaris. Despite the clinical and socioeconomic importance of ascariasis, many past routine surveys did not assess the intensity of Ascaris infection in people. We propose that the present findings might stimulate the development of customised strategies for the improved control and prevention of Ascaris infection worldwide.


Human ascariasis is one of the most important neglected tropical diseases (NTDs) worldwide [1]. It is caused by the intestinal nematode of the genus Ascaris—a soil-transmitted helminth (STH) [2]. Transmission occurs as a consequence of the accidental ingestion of embryonated eggs from contaminated soil, food and/or water. Ascaris eggs are resistant and have the potential to survive for long periods of time, particularly under warm and moist conditions [3]. Ascariasis is prevalent and has been estimated to affect ~ 819 million people [4]. The intensity of Ascaris infection is highest in children of 5 to 15 years of age, and has an over-dispersed or aggregated distribution, with most individuals harbouring light infections, and a relatively small proportion of the population harbouring heavy infection [5]. Furthermore, there is consistency in the pattern of re-infection or predisposition in humans [6].

Ascariasis can have acute and chronic manifestations, the latter being associated with significant nutritional and growth deficits [7]. Moreover, there is an association between ascariasis and impaired cognitive development, but the mechanism/s is/are not yet well understood [8]. Ascaris undergoes a larval migration via the liver and the lungs before establishing in the small intestine as a dioecious adult stage. This hepatopulmonary migration has significant, but underestimated pathological and public health impact, such as hepatic and pulmonary disorders [9]. Acute complications caused by adult worms might include intestinal impaction and/or obstruction of biliary and/or pancreatic ducts [7]. Despite the apparent rarity of acute ascariasis, such complications might have a high fatality rate [10].

The commonest method used for the diagnosis for Ascaris infection is the microscopic detection of eggs in faecal samples [11]. Counting adult worms upon expulsion following treatment is regarded as a “gold standard” for estimating the intensity of infection [11], but this approach is very rarely performed and only usually in the context of research projects, rather than routine parasite surveys or monitoring during large-scale deworming programmes.

Key epidemiological measures used to determine the extent of Ascaris infection are the prevalence of infection (% of persons infected in a particular population) and the intensity of infection. Intensity can be expressed as the arithmetic mean number of worms (“worm burden”), of eggs per gram of faeces (EPG), geometric mean EPG, or median EPG. The central importance of knowledge of prevalence and intensity of infection to the understanding of the epidemiology and impact of macroparasites in humans and other animals cannot be underestimated [5]. However, the number of routine surveys and monitoring programmes that utilise a measure of intensity remains low. In 2000, World Health Organization (WHO) recommended EPG thresholds (“cut-offs”) that can be used to classify infection intensity as low, moderate and high EPG [12].

Over the last few decades, large-scale deworming programmes have been implemented to “control” STHs in endemic regions. Despite variations in treatment efficacy among STHs, albendazole and mebendazole appear to remain efficacious anthelmintics against human ascariasis [13]. However, anthelmintic treatment alone will not lead to a marked reduction or elimination of ascariasis without accompanying improvements in socioeconomic conditions and the provision of clean water, improved sanitation and hygiene [14]. Thus, WHO set new targets that included the elimination of morbidity due to STHs (defined as the prevalence of moderate and heavy infection intensities of < 2%) in preschool- and school-age children by 2030 and universal access to at least basic sanitation and hygiene by 2030 in STH-endemic areas [15].

Pigs infected with Ascaris can represent a reservoir for human infection [16, 17], despite controversies about the species status of Ascaris of humans and pigs [16, 18, 19]. Part of the motivation to undertake the present review was the need to critically re-evaluate the extent of ascariasis in humans in endemic regions, since the last estimate in 2010, published in 2014 [4]. Here, we report a comprehensive systematic review and meta-analysis to estimate the prevalence and intensity of Ascaris infection in the general human population in endemic regions from 1 January 2010 to 1 January 2022. We also evaluated the impact of geographical, climatic and socio-demographic factors on the prevalence of Ascaris infection in different countries and regions.


Search strategy and selection criteria

This meta-analysis study was designed and conducted in accordance with the Cochrane Handbook of Systematic Reviews [20], and is reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [21] (Additional file 5: Checklist S1). Five investigators (C.H., H.B., A.A., G.D. and A.R.) began the search of the relevant studies on April 2020, through MEDLINE/PubMed, and Scopus, without language restriction. An updated search was performed on February 2022. Searches were limited to studies published between 1 January 2010 and 1 January 2022. The search terms used included: “ascariasis”, “Ascaris”, “Ascaris lumbricoides”, “intestinal parasites”, intestinal helminths”, “soil transmitted helminths”, “prevalence”, “incidence”, “epidemiology” and “occurrence”. These keywords were combined using Boolean operators ‘OR’ and/or ‘AND’ in database searches (Additional file 4: Fig. S1). To identify additional studies, the same investigators independently searched the Google Scholar engine, and scrunitised the reference lists of eligible studies. All citations retrieved were imported to Endnote software X8 (Thompson and Reuters, Philadelphia, USA), and 10,185 duplicates and irrelevant papers were deleted, leaving 1060 citations. Four independent investigators (S.M., S.V., A.A. and A.R.) reviewed the titles, abstracts, and full texts of articles for eligibility. The online tool “Google Translate” ( was used to assist the translation of articles published in languages other than English.

Selection criteria

Studies were considered eligible for inclusion if they were peer-reviewed, observational studies which reported the prevalence of Ascaris infection. Two trained researchers applied inclusion criteria: a sample size of at least 50; published after 1 January 2010; the tested population should be representative of the general population (i.e. randomly-selected people of different ages, socioeconomic status and ethnic backgrounds, without occupations or specific diseases increasing the probability of acquiring ascariasis); and studies that used an internationally accepted coprodiagnostic method with suitable performance characteristics (e.g., Kato-Katz, formalin-ether, McMaster, FLOTAC or Mini-FLOTAC techniques). In order to reduce bias in the estimation of ascariasis prevalence in the general population, studies of the following population groups were excluded: patients with gastrointestinal disorders, patients with diarrhoea, HIV+ patients, patients receiving corticosteroid treatment, patients with any immunodeficiency, haemodialysis patients, patients with tuberculosis, inmates in prisons, pregnant women, mentally retarded patients, immigrants, patients with atopy and other allergies, workers exposed to wastes, wastewater and faecal sludge. In addition, studies were excluded if they were: (1) comparing diagnostic methods; (2) serological investigations; (3) reporting an intervention approach, without the availability of baseline (reference) data; (4) used datasets that overlapped with those of other articles; (5) recorded prevalence after mass drug administration; (6) were performed in non-endemic areas, such as European and North American countries; (7) had a sample size of ≤ 50 individuals; (8) were case reports or series; or (9) were letters, commentaries, reviews or systematic reviews without original data.

Extraction and quality evaluation of data

A data collection form was developed in Microsoft Excel (version 2016; Microsoft Corporation, Redmond, USA); data were extracted independently by five investigators (H.B., S.V., G.D., S.G., S.M. and A.A.), and unanimity was reached on discrepancies after discussion, and also consultation with the senior investigators (C.H. and A.R.). Data were extracted for the following domains: (I) study characteristics (the first author's last name, year of publication, diagnostic methods, country; city, ‘sustainable development goal’ (SDG)-regions or sub-regions [22]); (II) participant characteristics [type of population (children, adult or both), the number of participants, the number of people that tested positive for Ascaris infection, age, sex, residence and intensity of infection (low, moderate, high)]; (III) socio-economic variables (World Bank–income category [23], gross national income per capita [23] and the human development index [HDI] [24]); and (IV) geo-climatic factors (latitude, longitude, mean relative humidity, mean annual precipitation and mean environmental temperature). The data sources for geo-climatic factors were:, and Furthermore, we recorded total global, regional populations (both sexes) in 2020, estimated by the United Nations [25]. For interventional studies, we extracted only baseline data, and for case-control studies, we only extracted data for healthy people. The data on intensity of Ascaris infection were extracted from studies that assessed and graded intensity according to the criteria defined by WHO [12]. The investigators independently assessed the risk of bias for each study using the Joanna Briggs Institute (JBI) Critical Appraisal Tools for cross-sectional, case-control, cohort and randomized controlled studies, and each study was categorized to have a low, moderate or high risk of bias, as recommended for these tools [26,27,28].


All statistical analyses were conducted using Stata statistical software (v.13 Stata Corp., College Station, TX, USA). The prevalence of Ascaris infection in each study was calculated by dividing the number of test-positive cases by the study population. To estimate the pooled prevalence of Ascaris infection, we used a DerSimonian and Laird random-effects model (REM) [29]. REM is capable of incorporating proportions close to, or at the margins (i.e., with a very low or very high prevalence), into conservative pooled prevalence estimates and 95% confidence intervals (CIs). We calculated the pooled prevalence rates at a 95% CI using the ‘metaprop’ command in Stata software. The pooled prevalence in each country was estimated by synthesizing the prevalence rates of all studies from the same country. We stratified estimates into the six endemic SDG regions and the 14 SDG sub-regions (Table 1). We estimated heterogeneity using the χ2 test with Cochran’s Q statistic and quantified with I2; I2 of > 75% was considered to reflect substantial heterogeneity [30]. To calculate the number of people infected with Ascaris, we extrapolated prevalence estimates to the total human population (in 2020) living in a country and/or a region—according to the UN Population Division [25]. Data were entered into ArcGIS 10.2 (ESRI, Redlands, CA, US) to produce maps presenting Ascaris infection prevalence estimates on a country level.

Table 1 Global and regional prevalence of Ascaris infection, and estimated numbers of infected people (results from 758 datasets performed in 81 countries)

We undertook several subgroup, as well as univariate and multivariate meta-regression, analyses to explore possible sources of heterogeneity and effects of socio-economic, study characteristics, geo-climatic parameters on the prevalence of Ascaris infection in people. These analyses were performed using the ‘metareg’ command in Stata [31] in relation to study participants (children, adults and total population); diagnostic method used; age, sex and residence; country income level (low, lower-middle, upper-middle or high) and country HDI (low, medium, high or very high); risk of bias levels for each study (low, moderate or high); geographical latitude and longitude; mean annual environmental temperature, relative humidity and precipitation; year of publication; and the start and end dates of sampling. Results were considered as statistically significant if the P value was < 0.1.


Study characteristics

Our search of electronic databases identified a total of 11,245 articles; following the removal of duplicate articles and a critical appraisal of article titles and abstracts, 1060 potentially relevant articles were identified for full-text evaluation (Fig. 1). After applying the eligibility criteria, 616 articles containing 758 datasets were included in the quantitative synthesis (Fig. 1); these datasets represented 4,923,876 people from 81 countries in six SDG regions and 14 SDG sub-regions. Of these datasets, 353 were from sub-Saharan Africa, 162 from Eastern & South-eastern Asia, 110 from Latin America and the Caribbean, 92 from Central and Southern Asia, 37 from Northern Africa and Western Asia, and four from Oceania. Considering SDG sub-regions; Eastern Africa (n = 184), Western Africa (n = 117), South-Eastern Asia (n = 97), Southern Asia (n = 89), and South America (n = 86) had highest eligible datasets, while Northern Africa (n = 7), Southern Africa (n = 6), Caribbean region (n = 4), Oceania (n = 4) and Central Asia (n = 3) had the lowest eligible datasets. The main characteristics of the studies included are provided in Additional file 1: Table S1. In this study, it should be noted that only populations in endemic areas were considered in the analyses; populations in North America, Europe and Australia & New Zealand were not considered.

Fig. 1
figure 1

The literature search strategy and study-selection process, indicating numbers of studies excluded and included

Global and regional prevalence of Ascaris infection

Overall, 164,879 people from a general population of 4,923,876 tested positive for Ascaris infection, indicating a pooled prevalence of 11.01% (95% CI: 10.27–11.78%). Significant heterogeneity (I2 = 99.8%, P < 0.001) was found between studies. The highest pooled prevalence estimates were for Central & Southern Asia (12.91%, 10.01–16.13%), Latin America & the Caribbean (12.75%, 10.75–14.88%) and sub-Saharan Africa (11.66%, 10.56–12.81%), while the lowest prevalence was from Northern Africa & Western Asia (2.04%, 1.47–2.70%) (Table 1). Considering the SDG sub-regions, the highest prevalence rates were: 28.77% (7.07–57.66%) in Melanesia (Oceania), 19.06% (15.51–22.87%) in South-Eastern Asia, 18.83% (13.04–25.42%) in Central America and 15.31% (11.39–19.69%) in Middle Africa, and the lowest prevalences were 1.39% (1.07–1.74%) in Eastern Asia, 1.71% (1.14–2.38%) in Western Asia, and 4.01% (0.85–9.20%) in Northern Africa (Table 1). Countries (for which ≥ 3 eligible studies were available) with the highest prevalence rates were Chad (48.19%), Liberia (42.45%), Ecuador (39.58%), Madagascar (37.16%), the Philippines (34.69%), Solomon Islands (33.96%), Indonesia (32.02%), Rwanda (31.22%) and Sri Lanka (30.81%) (Table 2). Figure 2 shows the Ascaris infection prevalence estimates for individual countries.

Table 2 Prevalence estimates of Ascaris infection, and estimated numbers of infected people in 81 countries
Fig. 2
figure 2

Estimated Ascaris infection prevalence rates in the general human population in different countries using the geographic information system (GIS)

An extrapolation to the 2020 world population indicated that ~ 731.8 million (range: 682,619,992 to 782,985,736) people harboured Ascaris infection. The sub-regions with the highest burden of Ascaris infection were Southern Asia (~ 254.1 million people), South-eastern Asia (~ 127.4 million people), South America (~ 49.8 million people), Eastern Africa (~ 49.5 million people) and Western Africa (~ 44.4 million people). More detail on the global and regional Ascaris infection prevalences and burdens are given in Table 1.

Intensity of Ascaris infection

In total, 137 of 758 datasets included information on the intensity of Ascaris infection (Additional file 2: Table S2). According to WHO guidelines, we appraised these data sets and estimated the prevalence of low, moderate and high intensities among infected people in each SDG region (for which ≥ 3 eligible studies were available). Our analyses showed that the highest prevalence of high intensity of Ascaris infection among infected people was found in Latin America and the Caribbean regions (8.35%, 3.88–14.11%), followed by Eastern and South-Eastern Asia (3.80%, 1.07–7.59%), Central and Southern Asia (0.62%, 0.01–0.63%), and Sub-Saharan Africa (0.26%, 0.01–0.97%). Our findings indicated that the prevalence of high intensity infection was lower in 2018–2021 (1.43%, 0.44–2.79%) compared with 2010–2013 (3.32%, 1.11–6.31%). Detail on low and moderate infection intensities are presented in Table 3.

Table 3 Intensity of Ascaris infection based upon numbers of infected people with cut-offs for low, medium or high intensity infection

Prevalence of Ascaris infection according to sex, age, residence and population

According to the type of population studied, 494 datasets related to children, 256 to both children and adults (all age groups) and eight studies to adults. In subgroup analysis, the global Ascaris infection was 13.50% (12.39–14.65%) in studies of children, 6.89% (6.19–7.63%) in studies of all age groups and 8.85% (1.53–20.25%) in studies recruiting only adults (Table 4).

Table 4 Prevalence estimates of Ascaris infection, according to a priori-defined subgroups and socio-demographic geographic parameters

Of the 616 studies included, 138 reported separate, pooled prevalence rates for males and females. Subgroup analysis revealed pooled prevalence of 14.67% (12.61–16.86%) in males and 14.61 (12.64–16.68%) in females. A total of 71 studies reported pooled prevalence rates for different age specific groups; a subgroup analysis revealed the lowest and highest prevalence rates of 14.14% (11.67–16.80%) and 25.82% (23.59–28.12%) in people of 12–18 and ≥ 51 years of age, respectively (Table 4). In addition, 143 studies reported prevalence rates for people in urban or rural regions; a subgroup analysis revealed that people living in rural areas had a higher prevalence (17.33%, 14.21–20.69%) of Ascaris infection than those living in urban areas (10.02%, 7.29–13.12%) (Table 4).

Prevalence of Ascaris infection in relation to diagnostic methods used and risk of bias

Various diagnostic methods were used in the studies included. We stratified these diagnostic methods into three categories: (1) the Kato-Katz method for 368 datasets (2) direct wet mount, formalin-ether and/or other routinely used sedimentation and/or concentration methods for 353 datasets; (3) other techniques, including McMaster, Lumbreras rapid sedimentation, Lutz sedimentation, flotation methods (FLOTAC and Mini-FLOTAC), Ritchie, Stoll’s dilution egg count and/or polymerase chain reaction (PCR) for 37 datasets. If more than one diagnostic test was used in a study and total positivity was recorded, we utilised this value; however, if this was not the case, we selected data relating to the diagnostic method that recorded the higher prevalence. Subgroup analysis revealed pooled prevalence rates of 12.68% (11.40–14.01%), 9.22% (8.45–10.01%), and 11.90% (7.29–17.43%) using Kato-Katz, routine parasitological methods, and other non-routine diagnostic methods, respectively (Table 4).

A critical appraisal using JBI tools showed that 378 datasets had a low risk of bias (score: 7–9/9), 269 datasets had a moderate (4–6/9), and 111 studies had a high risk of bias (≤ 3/9). Moreover, the prevalence for studies with a low, moderate and high risks of bias were 7.81% (6.94–8.73%), 14.28% (12.68–15.96%), and 16.23% (12.77–20.02%), respectively (Table 4).

Prevalence of Ascaris infection in relation to socio-demographic variables

For the 758 datasets included, 153, 385, 178 and 42 datasets represented countries with low, lower middle, upper middle and high income levels, respectively. Subgroup analysis (Table 4), according to income level, revealed the highest prevalence rates of Ascaris infection in countries with low (13.23%, 11.64–14.91%) and lower middle (12.17%, 10.89–13.52%) income levels, with the lowest prevalence estimated for high income countries (0.88%, 0.33–1.64%). On the other hand, totals of 273, 210, 190 and 85 datasets represented countries with low, medium, high and very high HDI levels. Subgroup analysis according to HDI level, indicated that the highest and lowest prevalence rates were estimated for countries with low (12.31%, 11.01–13.67%) and very high (5.01%, 3.90–6.25%) HDI levels (Table 4). Random-effects meta-regression analyses showed a significant, decreasing trend in prevalence with increasing income (coefficient [C] = − 4.37e−06; P-value = 0.0001) and HDI (C = − 0.145; P-value = 0.0001) levels (Additional file 4: Fig. S2A, B).

Prevalence of Ascaris infection over time

Another subgroup analysis was conducted to explore the prevalence of Ascaris infection over time. For this analysis, we stratified time into three categories: year of publication; year of the start of sampling; and year of the end of sampling. Subgroup analysis based on publication year showed prevalence rates of 9.18% (7.87–10.58%), 12.61% (11.15–14.15%), and 10.73% (9.57–11.95%) for studies published 2010–2013, 2014–2017 and 2018–2021, respectively (Table 4). Subgroup analyses according to the beginning and end dates of sampling, revealed that studies conducted between 2010 and 2015 reported the highest prevalence rates. Random-effects meta-regression analysis showed a non-significant, increasing trend in prevalence rates over time (C = 0.001; P-value = 0.4; Additional file 4: Fig. S3). Considering the start and end dates of sampling, subgroup analyses showed that studies between 2010 and 2015 reported higher prevalence rates than those performed before 2010 or between 2016 and 2021 (Table 4).

Relationship between the prevalence of Ascaris infection and geographical location/climate

According to geographical parameters, the highest and lowest prevalence rates were at latitudes 0–20° (13.41%, 12.34–14.51%), and 40–60° (0.53%, 0.17–1.04%); as well as longitudes at 60–80° (16.72%, 14.23–19.36%) and 40–60° (4.55%, 3.54–5.69%), respectively (Additional file 3: Table S3). Meta-regression analyses showed significant decreasing trends in prevalence with increasing geographical latitude (C = − 0.003, P-value < 0.001), while a non-significant increasing trend was observed with increasing geographical longitudes (C = 0.0001, P-value = 0.07) (Additional file 4: Fig. S4A, B).

Considering climate parameters, the highest prevalences were in regions with mean relative humidity of ≥ 80 (i.e. 18.60%, 15.54–21.86%), mean annual precipitation of > 200 mm (15.26%, 11.04–20.01%), and a mean annual temperature of 25–29 °C (14.81%, 13.24–16.46%), while the lowest prevalences were estimated for regions with a mean relative humidity of ≤ 40 (5.61%, 4.48–6.85%), a mean annual precipitation of 0–50 mm (4.72%, 4.02–5.48%), and a mean annual temperature of 9–13 °C (0.92%, 0.51–1.43%) (Additional file 3: Table S3). There was a significant, increasing prevalence trend with increasing relative humidity (C = 0.002; P-value < 0.001), precipitation rate (C = 0.000; P-value < 0.001) and environmental temperature (C = − 0.0006; P-value < 0.001) (Additional file 4: Fig. S5A–C).

Univariate and mulitivariate meta-regression analyses to identify source of heterogeneity

Additional file 3: Table S4 shows the results of the univariate and multivariate meta-regression analysis of study characteristics exploring the source of heterogeneity of the prevalence estimates Ascaris infection. As depicted in Additional file 3: Table S4, univariate analysis revealed that all covariates were significantly associated with heterogeneity of prevalence estimates, except for longitude (β, 0.05; 95% CI: − 0.00008–0.0005, P-value = 0.139), implementation year start (β, 0.05; 95% CI: − 0.001–0.004, P-value = 0.280), and implementation year start (β, 0.05; 95% CI: 0.03–0.06, P-value = 0.709). In the final multivariate meta-regression, the following variables including income level (β, 0.05; 95% CI: − 0.00007 to − 0.00002, P-value < 0.001), geographical longitude (β, 0.05; 95% CI: 0.0006–0.001, P-value < 0.001), temperature (β, 0.05; 95% CI: 0.001–0.006, P-value = 0.001), humidity (β, 0.05; 95% CI: 0.0003–0.002, P-value = 0.013), and; year of the start of sampling (β, 0.05; 95% CI: − 0.014 to − 0.0007, P-value = 0.030) remained significantly associated with heterogeneity of the prevalence of Ascaris infection.


Ascariasis continues to be an NTD of major public health significance worldwide, causing substantial morbidity in endemic regions [7]. Here, we performed a global systematic review and a meta-analysis of published studies of Ascaris infection in endemic regions. Our findings indicate that, globally, 11% of the ~ 6.6 billion people living in endemic regions, representing the ~ 732 million people, harbour Ascaris. When compared with the estimate by Pullan et al. [4], derived from data collected up to 2010, our estimates indicate a 3.5% reduction in prevalence (14.5% vs 11.0%) and a 10% reduction in the number of people with Ascaris infection (819 vs 730 million infected people). These findings are consistent with other recent studies [4, 32,33,34], reporting a reduction in the prevalence of STH infections globally. Pullan et al. [4] reported a substantial reduction in the prevalence of Ascaris infection in all endemic regions between 1990 (~ 32%) and 2010 (14.5%). Our findings from subgroup analyses also indicated a lower prevalence between 2016 and 2021 than between 2010 and 2015, although meta-regression analyses showed a non-significant, increasing trend over time. The likely explanation for this reduction in the prevalence of Ascaris infection in endemic regions is mass drug administration (MDA) within the context of control programmes [35].

Our results indicated that the prevalence of Ascaris infection varies among SDG regions and sub-regions, with the lowest prevalences (< 4%) in countries in Eastern Asia (China and the Republic of Korea) and Western Asia (Iraq, Iran, Palestine, Turkey and the United Arab Emirates) and the highest prevalences (> 20%) in some countries in Oceania (Papua New Guinea and the Solomon Islands), South-eastern Asia (Indonesia, Laos PDR, Malaysia, Myanmar, the Philippines, Sri Lanka and Vietnam), the Latin and Caribbean region (Brazil, Colombia, Ecuador, Honduras and Nicaragua), sub-Saharan Africa (including Angola, Burundi, Central African Republic, Chad, DR Congo and Madagascar) and South Asia (Afghanistan, Bangladesh, India and Pakistan). Lower prevalences in countries such as the Republic of Korea, China, Iran and Turkey are likely due to socio-economic improvements that have occurred over the past three decades [4, 36]. In tandem with community-based MDA, substantial improvements in personal and public hygiene (including the availability of toilets; hand washing before eating and after defaecation; consumption of washed vegetables and filtered water) have been achieved [37,38,39]. Improved water quality, sanitation and hygiene have been shown to be significantly associated with a lower prevalence of STHs, particularly Ascaris [39]. In contrast, a higher prevalence of Ascaris infection in South Asia, sub-Saharan Africa and Latin America might reflect less improvement in these measures. Furthermore, our results showed that the prevalence of Ascaris infection is higher in countries with lower levels of income and HDI.

Another explanation for the variation in prevalence of Ascaris infection in SDG regions is differences in environmental factors, such as temperature, humidity, rainfall, soil moisture, and contamination [40]. Environmental factors have an important impact on the embryonation of Ascaris eggs; consequently, egg development, viability and infectivity depend on a particular environmental temperature (≥ 25 °C) and humidity (≥ 55%) [41]. Some laboratory studies have demonstrated that higher temperature and humidity facilitates larval development, and other investigations have indicated that extreme humidity, desiccation and/or temperature can lead to compromised embryonation and larval development within eggs [41,42,43]. The present findings showed an increased prevalence of Ascaris infection in areas with higher environmental temperature, rainfall and humidity, such as in countries within South-East and Southern Asia, SubSaharan Africa and Latin America.

Another factor that may influence the observed variation in prevalence could be differential specificity and sensitivity of the diagnostic methods employed in individual studies. Diagnostic methods for the detection of Ascaris eggs include: direct microscopy of faecal smears, the Kato-Katz [44], McMaster [45], formol-ether concentration [46], FLOTAC [47] and mini-FLOTAC [48] techniques. The present investigation showed that 48.5% of studies included used the Kato-Katz method, as recommended by WHO. However, this latter method performs poorly when egg numbers in faecal samples are low [7, 49]. The remainder of the studies used a range of established methods. Variation in the standardisation and performance of diagnostic methods undoubtedly contributes to variability in estimates of prevalence and/or intensity of Ascaris infection. Molecular methods are now also being used or evaluated, including PCR-based detection of Ascaris DNA in faecal samples [50]. Some such approaches utilise a multiplex or a multi-parallel approach to detect and/or distinguish different parasite species [51, 52]. However, such methods are not yet in routine use around the world, as they require specialised equipment and trained personnel. Medley et al. [53] discussed some concerns about some coprodiagnostic methods employed for STHs, including Ascaris.

Despite the large number of studies reporting the global prevalence of Ascaris in humans, a major knowledge gap remains in relation to infection intensity. Only 19% of the datasets used in this systematic review contain information on infection intensity. “Intensity” was reported in a number of ways, but, most commonly, the proportion of individuals recorded to have low, moderate or high intensity was based upon EPG “cut-off”, in accord with 2002 WHO guidelines [12]. Without knowledge of infection intensity, it is challenging to assess the public health impact of a parasite such as Ascaris [1, 5]. The paucity of data on infection intensity is particularly problematic when (i) the prevalence is low; (ii) MDA is no longer implemented; and (iii) there is a need to identify high risk individuals who remain predisposed to heavy infection [6]. In tandem with the observed reduction in prevalence over time, we also observed a substantial reduction in the proportion of individuals with high intensity infection over time. The prevalence of moderate or high intensity infections is recommended as a key indicator of the success of whether STHs have been eliminated as a public health problem [54]. Therefore, this reduction of high intensity infections is of major epidemiological importance, and reflects, at least in part, the success of control strategies/programmes. Montresor et al. [55] also raised some issues regarding the implementation and effectiveness of preventative MDA in endemic regions. These authors reported that, of 96 countries endemic for ascariasis, four did not implement preventative MDA, 23 countries implemented preventative MDA without effective coverage, and 42 and 28 countries implemented MDA for < 5 and > 5 years, respectively.

An important issue that was not possible to evaluate in the present study, but should be highlighted, is the potential for cross transmission of Ascaris between pigs and humans (and vice versa). There has been considerable debate, over many years, as to species status of A. lumbricoides (humans) and A. suum (pigs), and whether they represent distinct species or operational taxonomic units that are reproductively isolated or are capable of interbreeding and producing viable offspring [17, 56]. Although their status is controversial, there is clear evidence that cross transmission of Ascaris occurs between pigs and humans living in close proximity, particularly in non-endemic regions [18, 57]. Some studies indicated that 4–7% of Ascaris from people in Guatemala and China were A. lumbricoides × A. suum ‘hybrids’ [19, 58]; other investigations have identified three main haplotype clusters (A, B and C) for Ascaris, employing part of the mitochondrial (mt) cytochrome c oxidase 1 (cox-1) gene (383 bp) as a marker [59,60,61,62]. There is genetic divergence between clusters: worms in clusters A and B (representing humans or pigs) were more closely related to each other, whereas worms in cluster C (from pigs or humans cross-infected with pig Ascaris) were genetically more distinct [16, 59, 60, 62]. It has been shown that haplotypes belonging to clusters A and B are geographically distributed worldwide in both host species (pig or human), but in different proportions [17]; the majority of worms studied in China belonged to cluster B [61], whereas most worms isolated from Uganda belonged to cluster A [59]; however, there was no clear geographical association. Moreover, important new information has recently emerged from a genome analysis of Ascaris worms recovered from human subjects in Kenya where pig husbandry is rare [16]. Most of these worms had mitochondrial genomes that clustered more closely to A. suum than to A. lumbricoides, suggesting that pig-Ascaris infection in people in Kenya might have been acquired previously from infected humans who had lived closely with pigs or non-human primates or another host animal harbouring pig-Ascaris, rather than from pigs [16, 63]. Phylogenetic analyses also revealed evidence to support a highly interbred Ascaris species genetic complex [16]. In many endemic regions, a close association between people and pigs is maintained and, therefore, may be one of the reasons for the persistence of Ascaris infection over time. However, it is not possible using the current coprodiagnostic methods to determine whether Ascaris hybrids do indeed exist.

Easton et al. [16] recommended that a One Health approach be employed for the control of human ascariasis, because pigs can serve as a reservoir for human Ascaris infection, also with potential implications for the spread of anthelmintic resistance. Evidence provided by these authors [16] also signals a need to utilise genome-based approaches to unravel the complexity of the enigmatic and controversial questions regarding the species status of human- and pig-Ascaris and host affiliation(s), and the genetic composition of Ascaris populations in both humans and pigs in different countries around the world.

The present study has a number of strengths. By including 616 studies and results for ~ 5 million people from 81 countries, this is one of the most comprehensive reviews on the epidemiology of Ascaris to date. We only included data for the ‘general population’ and excluded high risk groups, with the intent of minimising prevalence overestimates. However, this may have led to underestimates of Ascaris infection prevalence; therefore, our estimates might not be entirely representative of individuals in all communities. We also pooled data to highlight differences within and between different regions around the world, and assessed the impact of geographical, climatic and socio-economic factors on the prevalence of Ascaris infection.

However, some limitations of the present study are acknowledged. First, we included only studies listed in PubMed and Scopus; therefore we may have missed some studies, such as those published in non-indexed journals. However, we searched Google Scholar to identify additional, potentially relevant studies; nonetheless, given the large number of datasets studied, the inclusion of any potentially (unintentionally) omitted studies would not have significantly altered the overall findings. Second, as mentioned above, in some cases, our estimates might not be representative of national prevalences or of all communities in a country, particularly for those with small numbers of eligible studies. Data were not available for many countries, and there was insufficient data for some important endemic regions, including Central Asia, sub-Saharan Africa and Oceania. Moreover, estimates for countries such as Malaysia and Indonesia might not be truly representative of their whole population, because the majority of studies conducted in these countries focused on high-risk regions or communities. Although, in the present study, we included only studies published after 2010, in a substantial number of studies, sampling dates were before 2010 (see Table 4); therefore, as a result of changes in social and environmental conditions over time, the prevalence estimates from earlier studies may not have been entirely reflective of the infection status at the time. Third, few studies reported data on infection intensity or age/sex-specific prevalences. A fourth limitation is the existence of high heterogeneity recorded across all regions and sub-groupings, which is expected in global prevalence estimates across time periods and locations [64,65,66]; the sources of this heterogeneity are explained in our results.


The present findings on the prevalence and intensity of Ascaris infection should assist health policy makers in designing and supporting ascariasis intervention/control programmes that improve public health and reduce the burden of infection and disease. Our findings indicate that, despite a significant reduction in prevalence and intensity of Ascaris infection over past decades, a substantial portion of the world’s human population (i.e. ~ 732 million) is still infected with Ascaris, calling for enhanced efforts. Furthermore, despite its central epidemiological importance, many routine surveys fail to assess the intensity of Ascaris infection. This study calls for continued global efforts to control and prevent human ascariasis, to work toward achieving key SDGs by reducing the burden of STHs and increasing human health and wellbeing.

Availability of data and materials

The all data are presented in the manuscript and Additional files.



Neglected tropical diseases


Soil-transmitted helminth


Eggs per gram


World Health Organization


Preferred Reporting Items for Systematic Reviews and Meta-Analyses


Sustainable development goal


Joanna Briggs Institute


Random-effects model


Confidence intervals


Human development index


Polymerase chain reaction


  1. Holland C. Ascaris: the neglected parasite. London: Elsevier; 2013.

    Google Scholar 

  2. Loukas A, Maizels RM, Hotez PJ. The yin and yang of human soil-transmitted helminth infections. Int J Parasitol. 2021;51(13–14):1243–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Stephenson L, Holland C. The impact of helminth infections on human nutrition: schistosomes and soil-transmitted helminths. London: Taylor and Francis; 1987.

    Google Scholar 

  4. Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasites Vectors. 2014;7(1):1–19.

    Article  Google Scholar 

  5. Holland C. Predisposition to ascariasis: patterns, mechanisms and implications. Parasitology. 2009;136(12):1537–47.

    Article  CAS  PubMed  Google Scholar 

  6. Wright JE, Werkman M, Dunn JC, Anderson RM. Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review. Parasites Vectors. 2018;11(1):1–12.

    Article  Google Scholar 

  7. Else KJ, Keiser J, Holland CV, Grencis RK, Sattelle DB, Fujiwara RT, et al. Whipworm and roundworm infections. Nat Rev Dis Prim. 2020;6(1):1–23.

    Google Scholar 

  8. Nokes C, Bundy D. Does helminth infection affect mental processing and educational achievement? Parasitol Today. 1994;10(1):14–8.

    Article  CAS  PubMed  Google Scholar 

  9. Holland C. The long and winding road of Ascaris larval migration: the role of mouse models. Parasitology. 2021;148(14):1735–43.

    Article  Google Scholar 

  10. Villamizar E, Mendez M, Bonilla E, Varon H, de Ontra S. Ascaris lumbricoides infestation as a cause of intestinal obstruction in children: experience with 87 cases. J Pediatr Surg. 1996;31(1):201–5.

    Article  CAS  PubMed  Google Scholar 

  11. Walker M, Hall A, Basáñez MG. Ascaris lumbricoides: new epidemiological insights and mathematical approaches. In: Ascaris: the neglected parasite. London: Elsevier; 2013. p. 155–201.

    Chapter  Google Scholar 

  12. World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. Geneva: World Health Organization; 2002.

    Google Scholar 

  13. World Health Organization. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006.

    Google Scholar 

  14. Bartram J, Cairncross S. Hygiene, sanitation, and water: forgotten foundations of health. PLoS Med. 2010;7(11): e1000367.

    Article  PubMed  PubMed Central  Google Scholar 

  15. World Health Organization. 2030 targets for soil-transmitted helminthiases control programmes. Geneva: World Health Organization; 2020.

    Google Scholar 

  16. Easton A, Gao S, Lawton SP, Bennuru S, Khan A, Dahlstrom E, et al. Molecular evidence of hybridization between pig and human Ascaris indicates an interbred species complex infecting humans. Elife. 2020;9: e61562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nejsum P, Betson M, Bendall RP, Thamsborg SM, Stothard JR. Assessing the zoonotic potential of Ascaris suum and Trichuris suis: looking to the future from an analysis of the past. J Helminthol. 2012;86(2):148–55.

    Article  CAS  PubMed  Google Scholar 

  18. Nejsum P, Parker ED Jr, Frydenberg J, Roepstorff A, Boes J, Haque R, et al. Ascariasis is a zoonosis in Denmark. J Clin Microbiol. 2005;43(3):1142–8.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Peng W, Criscione CD. Ascariasis in people and pigs: new inferences from DNA analysis of worm populations. Infect Genet Evol. 2012;12(2):227–35.

    Article  PubMed  Google Scholar 

  20. Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. 2011.

  21. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. System Rev. 2015;4(1):1–9.

    Article  Google Scholar 

  22. The sustainable development goals (SDGs) report 2019. Regional groupings. Accessed 15 Aug 2020.

  23. World Bank Group database. Gross national income per capita 2019. Accessed 20 Mar 2022.

  24. United Nations Development Program. Human development index. Accessed 20 Mar 2022.

  25. United Nations. Total population (both sexes combined) by region, subregion and country, annually for 1950–2100 (thousands). Accessed 20 Mar 2022.

  26. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.

    Article  PubMed  Google Scholar 

  27. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Joanna Briggs institute reviewer’s manual. Adelaide: The Joanna Briggs Institute; 2017. p. 5.

    Google Scholar 

  28. Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness. In: Aromataris E, Munn Z, editors. JBI manual for evidence synthesis. JBI; 2020.

  29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

    Article  PubMed  Google Scholar 

  31. Harbord RM, Higgins JP. Meta-regression in Stata. Stata J. 2008;8(4):493–519.

    Article  Google Scholar 

  32. Lai Y-S, Biedermann P, Shrestha A, Chammartin F, à Porta N, Montresor A, et al. Risk profiling of soil-transmitted helminth infection and estimated number of infected people in South Asia: a systematic review and Bayesian geostatistical analysis. PLoS Negl Trop Dis. 2019;13(8): e0007580.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Silver ZA, Kaliappan SP, Samuel P, Venugopal S, Kang G, Sarkar R, et al. Geographical distribution of soil transmitted helminths and the effects of community type in South Asia and South East Asia—a systematic review. PLoS Negl Trop Dis. 2018;12(1): e0006153.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Dunn JC, Turner HC, Tun A, Anderson RM. Epidemiological surveys of, and research on, soil-transmitted helminths in Southeast Asia: a systematic review. Parasites Vectors. 2016;9(1):1–13.

    Article  Google Scholar 

  35. Clarke NE, Clements AC, Doi SA, Wang D, Campbell SJ, Gray D, et al. Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis. Lancet. 2017;389(10066):287–97.

    Article  PubMed  Google Scholar 

  36. Rokni M. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102(4):283–95.

    Article  CAS  PubMed  Google Scholar 

  37. Watson JA, Ensink JH, Ramos M, Benelli P, Holdsworth E, Dreibelbis R, et al. Does targeting children with hygiene promotion messages work? The effect of handwashing promotion targeted at children, on diarrhoea, soil-transmitted helminth infections and behaviour change, in low-and middle-income countries. Trop Med Int Health. 2017;22(5):526–38.

    Article  PubMed  Google Scholar 

  38. Bieri FA, Gray DJ, Williams GM, Raso G, Li YS, Yuan L, et al. Health-education package to prevent worm infections in Chinese schoolchildren. N Engl J Med. 2013;368(17):1603–12.

    Article  CAS  PubMed  Google Scholar 

  39. Strunz EC, Addiss DG, Stocks ME, Ogden S, Utzinger J, Freeman MC. Water, sanitation, hygiene, and soil-transmitted helminth infection: a systematic review and meta-analysis. PLoS Med. 2014;11(3): e1001620.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Cundill B, Alexander N, Bethony JM, Diemert D, Pullan RL, Brooker S. Rates and intensity of re-infection with human helminths after treatment and the influence of individual, household, and environmental factors in a Brazilian community. Parasitology. 2011;138(11):1406–16.

    Article  PubMed  Google Scholar 

  41. Maya C, Ortiz M, Jiménez B. Viability of Ascaris and other helminth genera non larval eggs in different conditions of temperature, lime (pH) and humidity. Water Sci Technol. 2010;62(11):2616–24.

    Article  CAS  PubMed  Google Scholar 

  42. Otto G. A study of the moisture requirements oî the eggs oî the horse, the dog, human and pig ascarids. Am J Hyg. 1929;10(2):497–520.

    Google Scholar 

  43. Beaver PC. Observations on the epidemiology of ascariasis in a region of high hookworm endemicity. J Parasitol. 1952;38(5):445–53.

    Article  CAS  PubMed  Google Scholar 

  44. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14(6):397–400.

    CAS  PubMed  Google Scholar 

  45. Levecke B, Behnke JM, Ajjampur SS, Albonico M, Ame SM, Charlier J, et al. A comparison of the sensitivity and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for soil-transmitted helminths. PLoS Negl Trop Dis. 2011;5(6): e1201.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Allen A, Ridley D. Further observations on the formol-ether concentration technique for faecal parasites. J Clin Pathol. 1970;23(6):545–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Cringoli G, Rinaldi L, Maurelli MP, Utzinger J. FLOTAC: new multivalent techniques for qualitative and quantitative copromicroscopic diagnosis of parasites in animals and humans. Nat Protoc. 2010;5(3):503–15.

    Article  CAS  PubMed  Google Scholar 

  48. Barda BD, Rinaldi L, Ianniello D, Zepherine H, Salvo F, Sadutshang T, et al. Mini-FLOTAC, an innovative direct diagnostic technique for intestinal parasitic infections: experience from the field. PLoS Negl Trop Dis. 2013;7(8): e2344.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Nikolay B, Brooker SJ, Pullan RL. Sensitivity of diagnostic tests for human soil-transmitted helminth infections: a meta-analysis in the absence of a true gold standard. Int J Parasitol. 2014;44(11):765–74.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Easton AV, Oliveira RG, O’Connell EM, Kepha S, Mwandawiro CS, Njenga SM, et al. Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming. Parasites Vectors. 2016;9(1):1–12.

    Article  Google Scholar 

  51. Mationg MLS, Gordon CA, Tallo VL, Olveda RM, Alday PP, Reñosa MDC, et al. Status of soil-transmitted helminth infections in schoolchildren in Laguna Province, the Philippines: determined by parasitological and molecular diagnostic techniques. PLoS Negl Trop Dis. 2017;11(11): e0006022.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Cunningham LJ, Stothard JR, Osei-Atweneboana M, Armoo S, Verweij JJ, Adams ER. Developing a real-time PCR assay based on multiplex high-resolution melt-curve analysis: a pilot study in detection and discrimination of soil-transmitted helminth and schistosome species. Parasitology. 2018;145(13):1733–8.

    Article  PubMed  Google Scholar 

  53. Medley G, Turner H, Baggaley R, Holland C, Hollingsworth T. The role of more sensitive helminth diagnostics in mass drug administration campaigns: elimination and health impacts. Adv Parasitol. 2016;94:343–92.

    Article  CAS  PubMed  Google Scholar 

  54. World Health Organization. Soil-transmitted helminthiases: eliminating as public health problem soil-transmitted helminthiases in children: progress report 2001–2010 and strategic plan 2011–2020. Geneva: World Health Organization; 2012.

    Google Scholar 

  55. Montresor A, Mupfasoni D, Mikhailov A, Mwinzi P, Lucianez A, Jamsheed M, et al. The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030. PLoS Negl Trop Dis. 2020;14(8): e0008505.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Betson M, Nejsum P, Stothard JR. From the twig tips to the deeper branches: new insights into evolutionary history and phylogeography of Ascaris. In: Ascaris: the neglected parasite. London: Elsevier; 2013. p. 265–85.

    Chapter  Google Scholar 

  57. Anderson T. Ascaris infections in humans from North America: molecular evidence for cross-infection. Parasitology. 1995;110(2):215–9.

    Article  PubMed  Google Scholar 

  58. Criscione CD, Anderson JD, Sudimack D, Peng W, Jha B, Williams-Blangero S, et al. Disentangling hybridization and host colonization in parasitic roundworms of humans and pigs. Proc R Soc Lond B Biol Sci. 2007;274(1626):2669–77.

    CAS  Google Scholar 

  59. Betson M, Nejsum P, Bendall RP, Deb RM, Stothard JR. Molecular epidemiology of ascariasis: a global perspective on the transmission dynamics of Ascaris in people and pigs. J Infect Dis. 2014;210(6):932–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Cavallero S, Snabel V, Pacella F, Perrone V, D’Amelio S. Phylogeographical studies of Ascaris spp. based on ribosomal and mitochondrial DNA sequences. PLoS Negl Trop Dis. 2013;7(4): e2170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Peng W, Yuan K, Hu M, Zhou X, Gasser RB. Mutation scanning-coupled analysis of haplotypic variability in mitochondrial DNA regions reveals low gene flow between human and porcine Ascaris in endemic regions of China. Electrophoresis. 2005;26(22):4317–26.

    Article  CAS  PubMed  Google Scholar 

  62. Nejsum P, Hawash MB, Betson M, Stothard JR, Gasser RB, Andersen LO. Ascaris phylogeny based on multiple whole mtDNA genomes. Infect Genet Evol. 2017;48:4–9.

    Article  CAS  PubMed  Google Scholar 

  63. Nejsum P, Bertelsen MF, Betson M, Stothard JR, Murrell KD. Molecular evidence for sustained transmission of zoonotic Ascaris suum among zoo chimpanzees (Pan troglodytes). Vet Parasitol. 2010;171(3–4):273–6.

    Article  CAS  PubMed  Google Scholar 

  64. Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55–79.

    Article  PubMed  Google Scholar 

  65. Kwatra G, Cunnington MC, Merrall E, Adrian PV, Ip M, Klugman KP, et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(9):1076–84.

    Article  PubMed  Google Scholar 

  66. Rostami A, Riahi S, Gamble H, Fakhri Y, Shiadeh MN, Danesh M, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(6):673–83.

    Article  CAS  PubMed  Google Scholar 

Download references


Sincere thanks to the Health Research Institute at the Babol University of Medical Sciences, Babol, Iran, for support during the preparation of the manuscript. RBG’s research has been supported predominantly by the Australian Research Council (ARC), the National and Medical Research Council of Australia (NHMRC) and key industry partners including Yourgene Health, Melbourne Water and Phylumtech.


There was no funder for this study. The corresponding author had full access to all study data and final responsibility for the decision to submit for publication.

Author information

Authors and Affiliations



AR and CH conceived the study. AR, HB, AA, GD and CH conducted the searches. HB, SV, GD, SG, SM and AA extracted data. AR, AA, MS and CH analysed the data sets and interpreted the results. AR, CH and RBG drafted and edited the manuscript. All authors commented on, or edited, and drafts the final version of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Robin B. Gasser or Ali Rostami.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Supplementary Information

Additional file 1: Table S1.

Main characteristics of the included studies.

Additional file 2: Table S2.

The main characteristics of studies that included intensity of Ascaris infection.

Additional file 3: Table S3.

Prevalence estimates for Ascaris infection based on sub-groups according to different geographic and climate parameters, calculated using a random effects model. Table S4. Association between study variables and heterogeneity of Ascariasis prevalence estimates.

Additional file 4: Figure S1.

Search strategy in databases. Figure S2. Random-effects meta-regression analyses of the prevalence of Ascaris infection in general population according to (A) a country's income level, showing a statistically significant downward trend in prevalence in countries with higher income levels; (B) human development index (HDI), showing a statistically significant downward trend in prevalence in countries with higher HDIs. Figure S3. Random-effects meta-regression analyses of the prevalence of Ascaris infection in the general human population, according to publication year, showing a statistically non-significant upward trend in prevalence in recent years. Figure S4. Random-effects meta-regression analyses of the prevalence of Ascaris infection in the general human population, according to (A) geographical latitude, showing a statistically significant downward trend in prevalence with increasing geographical latitude; and (B) geographical longitude, showing a statistically non-significant upward trend in prevalence with increasing geographical longitude. Figure S5. Random-effects meta-regression analyses of the prevalence of Ascaris infection in the general human population, according to (A) the mean annual relative humidity, showing a statistically significant upward trend in prevalence with increasing humidity; and (B) the mean annual precipitation rate, showing a statistically significant upward trend in prevalence with increasing precipitation; (C), the mean annual temperature, showing a statistically significant upward trend in prevalence with increasing environmental temperature.

Additional file 5: Checklist S1.

PRISMA checklist.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Holland, C., Sepidarkish, M., Deslyper, G. et al. Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis. Infect Dis Poverty 11, 113 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Ascaris
  • Global prevalence
  • Intensity of infection
  • Systematic review
  • Meta-analysis